AI Terminal
Eckert & Ziegler Strahlen- und Medizintechnik AG
Board/Management Information • May 31, 2017
130_rns_2017-05-31_675c8c48-51a0-43b7-8f32-405505dd6c01.html
Board/Management Information
Open in ViewerOpens in native device viewer
News Details
Corporate | 31 May 2017 17:12
Eckert & Ziegler: Acquisition of Gamma-Service successfully completed. Albert Rupprecht new member of the Supervisory Board.
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Takeover/Change of Personnel
31.05.2017 / 17:12
The issuer is solely responsible for the content of this announcement.
Berlin, May 31, 2017. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a Berlin-based company specializing in isotope technology for medical, scientific and industrial applications today signed an agreement to acquire its competitor Gamma-Service. Gamma-Service, a specialist in the manufacture of isotope technology products for medicine and industry, generated sales of approximately EUR 20 million in fiscal year 2016.
“With the purchase of essential parts of the Saxony-based Gamma-Service Group, we are strengthening our market position and focusing our energy now on the rapid and seamless integration of new businesses and employees, as well as the optimal servicing of our new and existing customers,” explained Dr. Andreas Eckert, Chief Executive Officer of
Eckert & Ziegler AG.
In addition, Albert Rupprecht was elected as a new member of the Supervisory Board at today’s Annual General Meeting. Mr. Rupprecht is the education and research policy spokesperson for the CDU/CSU faction in the German Bundestag. He succeeds Prof. Dr. Nikolaus Fuchs, who is stepping down from his position at the end of the Annual General Meeting on May 31, 2017. The Supervisory Board and Executive Board thanks Prof. Dr. Fuchs for his commitment and accomplishments for Eckert & Ziegler AG.
About Eckert & Ziegler
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) employs 760 people and is one of the world’s largest providers of isotope technology components for radiation therapy and nuclear medicine.
Contributing to saving lives.
Your contacts for inquiries:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.de
31.05.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | 49 30 941084-138 |
| Fax: | 49 30 941084-112 |
| E-mail: | [email protected] |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Stuttgart; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Tradegate Exchange |
| End of News | DGAP News Service |